首站-论文投稿智能助手
典型文献
Repurposing non-oncology small-molecule drugs to improve cancer therapy:Current situation and future directions
文献摘要:
Drug repurposing or repositioning has been well-known to refer to the therapeutic applications of a drug for another indication other than it was originally approved for.Repurposing non-oncology small-mole-cule drugs has been increasingly becoming an attractive approach to improve cancer therapy,with potentially lower overall costs and shorter timelines.Several non-oncology drugs approved by FDA have been recently reported to treat different types of human cancers,with the aid of some new emerging technologies,such as omics sequencing and artificial intelligence to overcome the bottleneck of drug repurposing.Therefore,in this review,we focus on summarizing the therapeutic potential of non-oncology drugs,including cardiovascular drugs,microbiological drugs,small-molecule antibiotics,anti-viral drugs,anti-inflammatory drugs,anti-neurodegenerative drugs,antipsychotic drugs,antidepressants,and other drugs in human cancers.We also discuss their novel potential targets and relevant signaling pathways of these old non-oncology drugs in cancer therapies.Taken together,these inspiring findings will shed new light on repurposing more non-oncology small-molecule drugs with their intricate molecular mechanisms for future cancer drug discovery.
文献关键词:
作者姓名:
Leilei Fu;Wenke Jin;Jiahui Zhang;Lingjuan Zhu;Jia Lu;Yongqi Zhen;Lan Zhang;Liang Ouyang;Bo Liu;Haiyang Yu
作者机构:
Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs,School of Life Science and Engineering,Southwest Jiaotong University,Chengdu 610031,China;State Key Laboratory of Biotherapy and Cancer Center West China Hospital,Sichuan University,Chengdu 610041,China;College of Traditional Chinese Materia Medica,Shenyang Pharmaceutical University,Shenyang 110064,China;State Key Laboratory of Component-based Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China
引用格式:
[1]Leilei Fu;Wenke Jin;Jiahui Zhang;Lingjuan Zhu;Jia Lu;Yongqi Zhen;Lan Zhang;Liang Ouyang;Bo Liu;Haiyang Yu-.Repurposing non-oncology small-molecule drugs to improve cancer therapy:Current situation and future directions)[J].药学学报(英文版),2022(02):532-557
A类:
B类:
Repurposing,oncology,small,molecule,drugs,improve,therapy,Current,situation,future,directions,Drug,repurposing,repositioning,has,been,well,known,refer,therapeutic,applications,another,indication,than,was,originally,approved,increasingly,becoming,attractive,approach,potentially,lower,overall,costs,shorter,timelines,Several,by,FDA,have,recently,reported,treat,different,types,human,cancers,aid,some,new,emerging,technologies,such,omics,sequencing,artificial,intelligence,overcome,bottleneck,Therefore,this,review,focus,summarizing,including,cardiovascular,microbiological,antibiotics,viral,inflammatory,neurodegenerative,antipsychotic,antidepressants,We,also,discuss,their,novel,targets,relevant,signaling,pathways,these,old,therapies,Taken,together,inspiring,findings,will,shed,light,more,intricate,molecular,mechanisms,discovery
AB值:
0.570337
相似文献
Drug repurposing for cancer treatment through global propagation with a greedy algorithm in a multilayer network
Xi Cheng;Wensi Zhao;Mengdi Zhu;Bo Wang;Xuege Wang;Xiaoyun Yang;Yuqi Huang;Minjia Tan;Jing Li-Department of Bioinformatics and Biostatistics,School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200240,China;The Chemical Proteomics Center and State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Key Laboratory of Tissue Microenvironment and Tumor,Shanghai Institute of Nutrition and Health,Shanghai Institutes for Biological Sciences,University of Chinese Academy of Sciences,Chinese Academy of Sciences(CAS),Shanghai 200031,China
Structures of the endogenous peptide-and selective non-peptide agonist-bound SSTR2 signaling complexes
Li-Nan Chen;Wei-Wei Wang;Ying-Jun Dong;Dan-Dan Shen;Jia Guo;Xuefei Yu;Jiao Qin;Su-Yu Ji;Huibing Zhang;Qingya Shen;Qiaojun He;Bo Yang;Yan Zhang;Qinglin Li;Chunyou Mao-Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital,Zhejiang University,School of Medicine,Hangzhou,Zhejiang,China;Department of General Surgery,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Center for Structural Pharmacology and Therapeutics Development,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Liangzhu Laboratory,Zhejiang University Medical Center,Hangzhou,Zhejiang,China;The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital),Hangzhou,Zhejiang,China;Zhejiang Province Key Laboratory of Anti-Cancer Drug Research,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou,Zhejiang,China;MOE Frontier Science Center for Brain Research and Brain-Machine Integration,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Zhejiang Provincial Key Laboratory of Immunity and Inflammatory diseases,Hangzhou,Zhejiang,China
Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages
Mei-yue Song;Jia-xin Wang;You-liang Sun;Zhi-fa Han;Yi-tian Zhou;Ying Liu;Tian-hui Fan;Zhao-guo Li;Xian-mei Qi;Ya Luo;Pei-ran Yang;Bai-cun Li;Xin-ri Zhang;Jing Wang;Chen Wang-Beijing University of Chinese Medicine,Beijing 100029,China;Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,China-Japan Friendship Hospital,Beijing 100029,China;National Clinical Research Center for Respiratory Diseases,Beijing 100029,China;Tsinghua-Peking Center for Life Sciences,Department of Biology,College of Medicine,Tsinghua University,Beijing 100084,China;School of Pharmaceutical Sciences,Tsinghua University,Beijing 100084,China;Department of Basic Medical Sciences,School of Medicine,Tsinghua University,Beijing 100084,China;Institute of Basic Medical Sciences Chinese Academy of Medical Sciences,School of Basic Medicine Peking Union Medical College,Beijing 100730,China;Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100730,China;Peking Union Medical College,MD Program,Beijing 100730,China;Department of Respiratory,The Second Affiliated Hospital of Harbin Medical University,Harbin 150086,China;Department of Pulmonary and Critical Care Medicine,The First Hospital of Shanxi Medical University,Taiyuan 030001,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。